SAN DIEGO, Nov. 13, 2021 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of: (1) Silverback Therapeutics Inc. (NASDAQ: SBTX) common stock pursuant and/or traceable to the offering documents issued in connection with…

Click here to view the original article.